HOUSTON, Aug. 12, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, provides a corporate update and announces its financial results for the quarter ended June 30,… Read More..

Reiterating timelines for FDA submission in 2025 Transplant clinical trial has attracted leading transplant hospitals Booked first revenue from first-generation GraftAssureIQ research-use-only kits; began shipping second generation kits in June NASHVILLE, Tenn., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today published the following… Read More..

(MENAFN- Investor Brand Network) SKYX Platforms (NASDAQ: SKYX) , doing business as SKYX Technologies, announced it will host a Corporate Update conference call to review its second quarter 2025 financial results on Tuesday, August 12, 2025, at 10:00 a.m. ET. The advanced smart home technology company, which holds more than… Read More..